Voriconazole nanopolymeric - Samyang Biopharmaceuticals Corporation
Alternative Names: SYP-1018; Voriconazole-loaded PNP; Voriconazole-PNPLatest Information Update: 10 Apr 2025
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Antifungals; Fluorinated hydrocarbons; Pyrimidines; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Mycoses
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 10 Apr 2025 Discontinued - Phase-I for Mycoses in South Korea (IV)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Mycoses in South Korea (IV)
- 31 May 2015 Final adverse events and pharmacokinetic data from a phase I trial in healthy volunteers released by Samyang Biopharmaceuticals